Cargando…

Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases

Chronic liver disease (CLD) entails elevated risk of COVID-19 severity and mortality. The effectiveness of the booster dose of inactivated SARS-CoV-2 vaccine in stimulating antibody response in CLD patients is unclear. Therefore, we conducted a cross-sectional study involving 237 adult CLD patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yongmei, Lu, Jianhua, Zhan, Haoting, Yuan, Wenfang, Li, Xiaomeng, Kang, Haiyan, Li, Haolong, Chen, Yongliang, Cheng, Linlin, Sun, Xingli, Zheng, Haojie, Wang, Wei, Dai, Erhei, Li, Yongzhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wuhan Institute of Virology, Chinese Academy of Sciences 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590695/ https://www.ncbi.nlm.nih.gov/pubmed/37487943 http://dx.doi.org/10.1016/j.virs.2023.07.005

Ejemplares similares

SARS-CoV-2 Vaccine Uptake among Patients with Chronic Liver Disease: A Cross-Sectional Analysis in Hebei Province, China
por: Liu, Yongmei, et al.
Publicado: (2023)

Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis
por: Zhan, Haoting, et al.
Publicado: (2023)

The Roles of Noncoding RNAs in Systemic Sclerosis
por: Liu, Yongmei, et al.
Publicado: (2022)

Roles of biomarkers in anti‐MDA5‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
por: Li, Xiaomeng, et al.
Publicado: (2022)

Alterations of m6A RNA methylation regulators contribute to autophagy and immune infiltration in primary Sjögren’s syndrome
por: Cheng, Linlin, et al.
Publicado: (2022)

Plasma lipidomics of primary biliary cholangitis and its comparison with Sjögren’s syndrome
por: Li, Haolong, et al.
Publicado: (2023)

Development and validation of diagnostic and activity-assessing models for relapsing polychondritis based on laboratory parameters
por: Liu, Yongmei, et al.
Publicado: (2023)

Antibody response to inactivated COVID‐19 vaccine in patients with type 2 diabetes mellitus after the booster immunization
por: Li, Haolong, et al.
Publicado: (2023)

Circulating VEGF-A, TNF-α, CCL2, IL-6, and IFN-γ as biomarkers of cancer in cancer-associated anti-TIF1-γ antibody-positive dermatomyositis
por: Li, Xiaomeng, et al.
Publicado: (2022)

Association of Circulating Vascular Endothelial Growth Factor Levels With Autoimmune Diseases: A Systematic Review and Meta-Analysis
por: Zhan, Haoting, et al.
Publicado: (2021)

Novel Insights Into Gene Signatures and Their Correlation With Immune Infiltration of Peripheral Blood Mononuclear Cells in Behcet’s Disease
por: Zhan, Haoting, et al.
Publicado: (2021)

Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression
por: Zhan, Haoting, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunization
por: Chen, Chen, et al.
Publicado: (2023)

Identification of hub biomarkers and immune cell infiltration in polymyositis and dermatomyositis
por: Chen, Si, et al.
Publicado: (2022)

Identification of novel genes in Behcet’s disease using integrated bioinformatic analysis
por: Chen, Si, et al.
Publicado: (2022)

Chemokines and chemokine receptors in Behçet’s disease
por: Li, Zhan, et al.
Publicado: (2023)

COVID-19 vaccination status, side effects, and perceptions among breast cancer survivors: a cross-sectional study in China
por: Xu, Yali, et al.
Publicado: (2023)

Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
por: Xu, Xingli, et al.
Publicado: (2022)

Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains
por: Xiao, Chanchan, et al.
Publicado: (2022)

Inactivated SARS-CoV-2 Vaccine Booster Against Omicron Infection Among Quarantined Close Contacts
por: Liu, Di, et al.
Publicado: (2023)

The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021)

Ferritin in the coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
por: Cheng, Linlin, et al.
Publicado: (2020)

Diagnostic value of anti‐citrullinated α‐enolase peptide 1 antibody in patients with rheumatoid arthritis: A systematic review and meta‐analysis
por: Li, Haolong, et al.
Publicado: (2021)

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
por: Tung, Tao-Hsin, et al.
Publicado: (2022)

Association of GTF2I, NFKB1, and TYK2 Regional Polymorphisms With Systemic Sclerosis in a Chinese Han Population
por: Liu, Chenxi, et al.
Publicado: (2021)

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
por: Wang, Xun, et al.
Publicado: (2022)

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
por: Méndez, Constanza, et al.
Publicado: (2023)

Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine
por: Fan, Shengtao, et al.
Publicado: (2021)

Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine
por: He, Xiaomeng, et al.
Publicado: (2023)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Seminal Plasma Lipidomics Profiling to Identify Signatures of Kallmann Syndrome
por: Li, Xiaogang, et al.
Publicado: (2021)

Distinct metabolic biomarkers to distinguish IgG4-related disease from Sjogren’s syndrome and pancreatic cancer and predict disease prognosis
por: Yan, Songxin, et al.
Publicado: (2022)

A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice
por: Zhang, Rong, et al.
Publicado: (2022)

Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine
por: Meng, Ziyan, et al.
Publicado: (2022)

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
por: Lv, Zhengchao, et al.
Publicado: (2023)

Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases
por: Chauhan, Mahak, et al.
Publicado: (2022)

Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
por: Yi, Yunyun, et al.
Publicado: (2023)

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
por: Croda, Julio, et al.
Publicado: (2022)

94: ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS AND THOSE WITH CHRONIC LIVER DISEASES
por: Chauhan, Mahak, et al.
Publicado: (2022)

Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study
por: Jara, Alejandro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ldm5ek7kiuc4uevk5s1mkah8uj